Fig. 1From: Cost utility analysis of cryopreserved amniotic membrane versus topical cyclosporine for the treatment of moderate to severe dry eye syndromeDecision tree: Prokera vs. Standard of Care (Cyclosporine A; Restasis)Back to article page